Human Papilloma Virus

HPV vaccination was effective in preventing penile HPV infection in transgender women and men who have sex with men when the vaccine was administered before and up to age 18 years, researchers reported in The Journal of Infectious Diseases.

Women in Appalachia are disproportionately affected by cervical cancer, according to the Ohio State University Comprehensive Cancer Center.

Amid the COVID-19 pandemic, people are putting off care, letting self-care strategies slip and falling back into unhealthy habits as they spend more time isolated and at home.

Most children and adolescents with HIV mounted antibody responses to the quadrivalent HPV vaccine, according to a study presented at IDWeek.

Early post-therapy clearance of HPV appeared associated with improved survival among women with cervical cancer, according to results of a prospective study published in Cancer.

Quadrivalent HPV vaccination substantially reduced the risk for invasive cervical cancer among Swedish girls and women aged 10 to 30 years, according to results of a study published in The New England Journal of Medicine.

September is Gynecologic Cancer Awareness Month, an awareness campaign launched in 1999 by Foundation for Women’s Cancer.

HPV and meningococcal vaccination coverage among adolescents aged 13 to 17 years in the United States continues to improve, although geographical disparities persist, according to findings published in MMWR.

An updated guideline issued by the American Cancer Society recommends cervical cancer screening with the HPV test every 5 years from age 25 years to 65 years.

The FDA recently expanded the indication of HPV 9-valent vaccine, recombinant. It was the top story in hematology/oncology last week.